Skip to main content
. 2020 Jul 4;9(7):379. doi: 10.3390/antibiotics9070379

Figure 1.

Figure 1

Adjusted efficacy estimates (y-axis) depending on endpoint specificity (x-axis) applying Equation (7) with 0.95 confidence intervals and using Equation (9) for the primary endpoint of the CAPRISA 004 trial.